DK360388A - Laegemiddel til behandling af hjerteinsufficiens - Google Patents

Laegemiddel til behandling af hjerteinsufficiens

Info

Publication number
DK360388A
DK360388A DK360388A DK360388A DK360388A DK 360388 A DK360388 A DK 360388A DK 360388 A DK360388 A DK 360388A DK 360388 A DK360388 A DK 360388A DK 360388 A DK360388 A DK 360388A
Authority
DK
Denmark
Prior art keywords
infficiency
heart
medicine
treatment
group
Prior art date
Application number
DK360388A
Other languages
Danish (da)
English (en)
Other versions
DK360388D0 (da
Inventor
Kiyoshi Irie
Satoshi Kunitada
Shinichiro Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of DK360388D0 publication Critical patent/DK360388D0/da
Publication of DK360388A publication Critical patent/DK360388A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK360388A 1987-07-01 1988-06-30 Laegemiddel til behandling af hjerteinsufficiens DK360388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16438787 1987-07-01

Publications (2)

Publication Number Publication Date
DK360388D0 DK360388D0 (da) 1988-06-30
DK360388A true DK360388A (da) 1989-01-02

Family

ID=15792156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK360388A DK360388A (da) 1987-07-01 1988-06-30 Laegemiddel til behandling af hjerteinsufficiens

Country Status (12)

Country Link
US (1) US4933349A (cg-RX-API-DMAC10.html)
EP (1) EP0297593B1 (cg-RX-API-DMAC10.html)
JP (1) JPH01104013A (cg-RX-API-DMAC10.html)
KR (1) KR960007752B1 (cg-RX-API-DMAC10.html)
AT (1) ATE88634T1 (cg-RX-API-DMAC10.html)
AU (1) AU609834B2 (cg-RX-API-DMAC10.html)
CA (1) CA1309028C (cg-RX-API-DMAC10.html)
DE (1) DE3880564T2 (cg-RX-API-DMAC10.html)
DK (1) DK360388A (cg-RX-API-DMAC10.html)
IL (1) IL86846A (cg-RX-API-DMAC10.html)
PH (1) PH24636A (cg-RX-API-DMAC10.html)
ZA (1) ZA884697B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5354770A (en) * 1989-02-27 1994-10-11 Daiichi Pharmaceutical Co., Ltd. Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
ZA901416B (en) * 1989-02-27 1990-12-28 Daiichi Seiyaku Co Post-ptca restenosis inhibitor
WO1991015207A1 (en) * 1990-04-09 1991-10-17 Daiichi Pharmaceutical Co., Ltd. Remedy for obstructive pulmonary disease
AU2001247060A1 (en) * 2000-11-07 2002-05-21 Lozon Llc Splicing device and method for sealing conduit spaces
US10130267B2 (en) * 2012-03-08 2018-11-20 Medtronic, Inc. Heart sound monitoring of pulmonary hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative

Also Published As

Publication number Publication date
JPH0552813B2 (cg-RX-API-DMAC10.html) 1993-08-06
CA1309028C (en) 1992-10-20
EP0297593B1 (en) 1993-04-28
DE3880564T2 (de) 1993-08-12
KR960007752B1 (ko) 1996-06-12
DK360388D0 (da) 1988-06-30
IL86846A (en) 1992-03-29
EP0297593A3 (en) 1990-08-01
PH24636A (en) 1990-08-17
EP0297593A2 (en) 1989-01-04
DE3880564D1 (de) 1993-06-03
AU609834B2 (en) 1991-05-09
AU1855088A (en) 1989-01-05
US4933349A (en) 1990-06-12
ZA884697B (en) 1989-03-29
ATE88634T1 (de) 1993-05-15
KR890001540A (ko) 1989-03-27
JPH01104013A (ja) 1989-04-21

Similar Documents

Publication Publication Date Title
NO932442D0 (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved behandling av hepatitt b
HU9301866D0 (en) Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
DK0659427T3 (da) 2-Phenyl-3-azoylbenzothiophener til forøgelse af thrombomodulinekspression
FI102896B1 (fi) Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
MX9206093A (es) Derivado de oxazolidona
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
EP0314275A3 (en) 2-pyrrolidone-5-carboxylic acid compounds
NO872781L (no) 4-(aroylamino)piperidinbutanamid-derivater.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DK74189D0 (da) Laegemiddel til behandling af mavesaar
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
NO900636L (no) Fremgangsmaate for fremstilling av indolderivater.
DE69411852D1 (de) Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten
ATE124259T1 (de) Thiazolidine-2,4-dione für die behandlung der hypertonie.
KR890009886A (ko) 심기능 부전의 예방 및 치료제
DK653687D0 (da) Middel til behandling af nyresygdomme
DE3884878D1 (de) Uricosuretische Zusammensetzung.
DK0437645T3 (da) Imidazolylpropylguanidinderivat, fremgangsmåde til fremstilling deraf og lægemidler indeholdende denne forbindelse
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment